Healthcare | March 14, 2026
Aster DM bags overwhelming shareholder backing for merger with Quality Care
The endorsement follows overwhelming support for the share swap preceding the merger,
The endorsement follows overwhelming support for the share swap preceding the merger,
The protections extend through at least 2035, with the potential for further extensions
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Marks significant milestone for breakthrough biologic to treat rare blood cancers
Launches advanced bone density systems in India & Dubai
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
The FDA classified LifeVac as a Class II medical device
Diasens and GlucoLive are designed for diabetic, Chronic Kidney Disease (CKD), and post-transplant patients who require continuous glycaemic surveillance and integrated remote care
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
Germany will be the first launch market
Subscribe To Our Newsletter & Stay Updated
